New FDA - OA REMS Announcement | by: Deneen Fumich, RPh | Article Posted: May 2, 2023 | April 21, 2022, FDA published in the Federal Register open comments under the Support Act which authorized FDA to require through a Risk Evaluation and Mitigation Strategy (REMS)...
FDA – OA REMS Announcement Concerning requirements to Manufacturers of Opioids
read more